Chesterfield, MO, United States of America

D Joseph Rogier, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Joseph Rogier, Jr. Retrieved from https://idiyas.com/inventor/d-joseph-rogier-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: D Joseph Rogier, Jr: Innovator in Pharmaceutical Chemistry

Introduction

D Joseph Rogier, Jr. is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have potential therapeutic applications.

Latest Patents

D Joseph Rogier, Jr. holds a patent for Pyridine [3,4-b] pyrazinones. This patent discloses compounds and pharmaceutically acceptable salts of the compounds, which have a specific structure defined in the specification. The patent also includes corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates.

Career Highlights

He is associated with Pharmacia & Upjohn Company, where he has been able to apply his expertise in developing new pharmaceutical compounds. His work has contributed to advancements in the treatment of various medical conditions.

Collaborations

D Joseph Rogier, Jr. has collaborated with notable colleagues such as Robert Owen Hughes and Andrew Simon Bell. These collaborations have likely enhanced the scope and impact of his research and innovations.

Conclusion

D Joseph Rogier, Jr. exemplifies the spirit of innovation in the pharmaceutical industry through his patent and collaborative efforts. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…